FeesSafety
Pluang+

Investigations launched into merger deals of Lumentum, Surgery Partners, Range Resources, and American Oncology Network.

02 Nov 2026, 18:20 WIB
GlobeNewsWire
View Source
Bearish
Investigations launched into merger deals of Lumentum, Surgery Partners, Range Resources, and American Oncology Network.

Brodsky & Smith LLC has announced investigations into the merger agreements of four companies: Lumentum Holdings, Surgery Partners, Range Resources, and American Oncology Network. These investigations focus on whether the boards of these companies breached their fiduciary duties by not conducting a fair process or offering fair value to shareholders in their respective acquisition deals. The mergers involve significant transactions, including Lumentum's $115 billion deal with Marvell Technology and Range Resources' $50 billion deal with EQT Corporation. Investors holding shares in these companies are encouraged to contact Brodsky & Smith for more information, with no cost or obligation involved.

Lumentum Holdings has a market cap of $76.15 billion and an enterprise value of $75.09 billion on Pluang as of Nov 02, 2026 23:41 WIB, with a notable 1-day price drop of 13.12%. Range Resources Corporation shows a market cap of $12.77 billion and a dividend yield of 0.73%, with its price slightly up by 0.37% on the same date. These figures highlight the current trading environment for the companies involved in the merger investigations.

More News (LITE)

Ademi LLP probes if Marvell's $115B buyout offer fairly values Lumentum shares at $1,132 each.

Ademi LLP probes if Marvell's $115B buyout offer fairly values Lumentum shares at $1,132 each.

Ademi LLP is investigating whether Marvell's proposed acquisition of Lumentum, valued at about $115 billion or $1,132 per share, offers fair value to Lumentum shareholders. The law firm is examining the purchase price, benefits to company insiders, r...

Market News
Bearish
8 hours ago
Lumentum Holdings rated Sell; stock price seen overvalued amid supply and margin concerns.

Lumentum Holdings rated Sell; stock price seen overvalued amid supply and margin concerns.

Lumentum Holdings is rated Sell with a fair value estimate of $400 per share, significantly below its recent closing price of $840.70. While the company's laser business benefits from a strong competitive moat and growing demand in AI networking infr...

Company Fundamentals
Bearish
1 day ago
AI optics stocks drop sharply as fears over hyperscaler spending hit after Google's big cash burn.

AI optics stocks drop sharply as fears over hyperscaler spending hit after Google's big cash burn.

AI optics stocks including Applied Optoelectronics, Coherent, Lumentum, and Marvell fell between 10% and 15% following concerns about hyperscaler spending after Google's market value dropped by over $500 billion due to higher-than-expected cash burn....

Bearish
3 days ago
Marvell nears deal to buy Lumentum, shares split as buyers and sellers react sharply.

Marvell nears deal to buy Lumentum, shares split as buyers and sellers react sharply.

Marvell is reportedly close to acquiring optical component maker Lumentum, a move that has caused Marvell's shares to drop 13% while Lumentum's rose 6%. The deal aims to secure scarce optical components critical for AI data centers, with Lumentum's p...

Market News
Neutral
4 days ago
Marvell nears $83B deal to buy AI laser maker Lumentum, shares diverge post-hours on deal risks.

Marvell nears $83B deal to buy AI laser maker Lumentum, shares diverge post-hours on deal risks.

Marvell Technology is reportedly in advanced talks to acquire Lumentum Holdings, an $83 billion AI laser and optical components maker critical for data center AI infrastructure. The deal would combine Marvell's custom silicon and photonics with Lumen...

Market News
Neutral
4 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App